Healthcare provider profile · identity verified

Leonard Dubin, M.D.

Internal Medicine · MELROSE PARK, IL · NPI 1518976737

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	450	134
Metformin Hcl	Metformin Hcl	320	93
Levothyroxine Sodium	Levothyroxine Sodium	315	83
Rosuvastatin Calcium	Rosuvastatin Calcium	307	93
Gabapentin	Gabapentin	287	100
Omeprazole	Omeprazole	261	86
Losartan Potassium	Losartan Potassium	254	65
Tamsulosin Hcl	Tamsulosin Hcl	246	84
Amlodipine Besylate	Amlodipine Besylate	243	76
Meloxicam	Meloxicam	239	100
Metoprolol Succinate	Metoprolol Succinate	206	67
Alprazolam	Alprazolam	173	44
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	158	19
Pantoprazole Sodium	Pantoprazole Sodium	149	43
Simvastatin	Simvastatin	149	37
Glimepiride	Glimepiride	142	36
Azithromycin	Azithromycin	141	89
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	117	32
Lisinopril	Lisinopril	113	36
Triamcinolone Acetonide	Triamcinolone Acetonide	109	67
Clopidogrel	Clopidogrel Bisulfate	104	27
Sertraline Hcl	Sertraline Hcl	100	29
Carvedilol	Carvedilol	99	28
Tramadol Hcl	Tramadol Hcl	99	29
Olmesartan Medoxomil	Olmesartan Medoxomil	97	29
Eliquis	Apixaban	93	26
Furosemide	Furosemide	88	34
Mirtazapine	Mirtazapine	82	30
Diclofenac Sodium	Diclofenac Sodium	81	18
Methylprednisolone	Methylprednisolone	81	54
Ozempic	Semaglutide	77	14
Meclizine Hcl	Meclizine Hcl	76	35
Metoprolol Tartrate	Metoprolol Tartrate	74	27
Famotidine	Famotidine	72	24
Hydrochlorothiazide	Hydrochlorothiazide	71	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	59	17
Lorazepam	Lorazepam	59	11
Zolpidem Tartrate	Zolpidem Tartrate	59	18
Escitalopram Oxalate	Escitalopram Oxalate	57	20
Pravastatin Sodium	Pravastatin Sodium	57	16
Linzess	Linaclotide	56	16
Tradjenta	Linagliptin	56	15
Trazodone Hcl	Trazodone Hcl	55	19
Solifenacin Succinate	Solifenacin Succinate	54	21
Albuterol Sulfate Hfa	Albuterol Sulfate	52	16
Breo Ellipta	Fluticasone/Vilanterol	52	14
Fluticasone Propionate	Fluticasone Propionate	52	21
Ibandronate Sodium	Ibandronate Sodium	52	17
Potassium Chloride	Potassium Chloride	52	24
Nebivolol Hcl	Nebivolol Hcl	51	suppressed
Allopurinol	Allopurinol	50	11
Jardiance	Empagliflozin	50	16
Diazepam	Diazepam	49	suppressed
Pregabalin	Pregabalin	48	16
Acetaminophen-Codeine	Acetaminophen With Codeine	47	19
Glipizide	Glipizide	44	11
Levofloxacin	Levofloxacin	44	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	14
Janumet	Sitagliptin Phos/Metformin Hcl	41	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	41	14
Prednisone	Prednisone	39	14
Finasteride	Finasteride	37	11
Trulicity	Dulaglutide	37	12
Vitamin D2	Ergocalciferol (Vitamin D2)	37	11
Hydralazine Hcl	Hydralazine Hcl	36	12
Lovastatin	Lovastatin	36	suppressed
Celecoxib	Celecoxib	34	11
Amiodarone Hcl	Amiodarone Hcl	33	11
Clonazepam	Clonazepam	33	11
Ramipril	Ramipril	33	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	17
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	32	15
Ibuprofen	Ibuprofen	32	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	30	16
Nifedipine Er	Nifedipine	30	suppressed
Alendronate Sodium	Alendronate Sodium	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Clotrimazole	Clotrimazole	26	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Telmisartan	Telmisartan	26	suppressed
Enalapril Maleate	Enalapril Maleate	25	suppressed
Fluconazole	Fluconazole	25	14
Atenolol	Atenolol	24	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Indomethacin	Indomethacin	24	suppressed
Glipizide Er	Glipizide	23	suppressed
Terbinafine Hcl	Terbinafine Hcl	23	18
Doxycycline Hyclate	Doxycycline Hyclate	22	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	22	11
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Vascepa	Icosapent Ethyl	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	11
Montelukast Sodium	Montelukast Sodium	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	14
Alfuzosin Hcl Er	Alfuzosin Hcl	19	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	19	suppressed
Primidone	Primidone	19	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Midodrine Hcl	Midodrine Hcl	18	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	11
Gemfibrozil	Gemfibrozil	15	suppressed
Methimazole	Methimazole	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Dutasteride	Dutasteride	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Valsartan	Valsartan	14	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Calcitriol	Calcitriol	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	13	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Humira Pen	Adalimumab	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Torsemide	Torsemide	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error